The 2024 EULAR recommendations provide updated guidance on the safe use of antirheumatic drugs in reproduction, pregnancy and lactation — timely given the expansion of available therapies.

Fate Therapeutics, Inc. (NASDAQ:FATE) is among the best get rich quick stocks to buy now. Analysts at H.C. Wainwright have reaffirmed their Neutral rating on Fate Therapeutics, Inc. (NASDAQ:FATE ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed ...

The best life insurance companies for children in August 2025 A life insurance policy can guarantee coverage for your child later in life and has other benefits.

Get the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock news and headlines to help you in your trading and investing decisions.

Business Wire Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025 12 Jun 2025 DARMSTADT, Germany Not intended for UK-, US- or Canada ...

UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.

Read about Tonix Pharmaceuticals Holding Corp (TNXP:XNAS) stock and today's latest news and financial updates.